Brief: ALK Peanut Tablet Shown To Be Safe, Tolerable For All Dose Levels
18/01/2024 14:37
Jan 18 (Reuters) - ALK-Abello A/S ALKb.CO :
* COMPLETES FIRST PART OF PHASE 1 TRIAL WITH PEANUT SLIT-TABLET
* FOR ALL DOSE LEVELS, PEANUT TABLET WAS SHOWN TO BE SAFE AND TOLERABLE
* 2ND PART OF TRIAL WITH PEANUT SLIT-TABLET EXPECTED TO COMPLETE LATER IN 2024
* HAS DECIDED TO AMEND ALLIANCE STUDY PROTOCOL TO INCLUDE A THIRD PART INVOLVING
APPROXIMATELY 100
ADDITIONAL PATIENTS
Source text for Eikon: ID:nGNE7lhKmp
Further company coverage: ALKb.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))